Drugmakers Regeneron Pharmaceuticals Inc. and Sanofi SA are racing to launch clinical trials exploring whether their arthritis drug could treat symptoms of novel coronavirus infections.

The study preparations mark the latest effort in an emerging front in researchers’ hunt for effective treatments for Covid-19, the respiratory disease caused by the novel coronavirus. In the U.S., there aren’t any drugs or vaccines approved for the condition.

...